title: One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy.
authors.forename: A
authors.initials: A
authors.lastname: Miki
authors.forename: Y
authors.initials: Y
authors.lastname: Oshima
authors.forename: Y
authors.initials: Y
authors.lastname: Otori
authors.forename: K
authors.initials: K
authors.lastname: Matsushita
authors.forename: K
authors.initials: K
authors.lastname: Nishida
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D005500:Follow-Up Studies; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D014130:Trabeculectomy / Q000379:methods*; D014821:Vitrectomy
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab